DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Bayer AG (ADR) (NASDAQOTH: BAYRY)

0.00 -141.89 (-100.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BAYRY $0.00 -100.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $140.75
Previous Close $141.89
Daily Range $140.25 - $141.20
52-Week Range $125.02 - $156.77
Market Cap $0.00
P/E Ratio 783.61
Dividend (Yield) $0.00 (1.3%)
Volume 192,584
Average Daily Volume 93,726
Current FY EPS $8.03

Sector

Healthcare

Industry

Pharma

Bayer AG (ADR) (BAYRY) Description

The Company offers products, including ethical pharmaceuticals and other health care products, agricultural products and polymers. Website:

News & Commentary

3 Reasons Monsanto Stock Could Rise

There's plenty of reasons why the seed and chemicals giant can break out of its funk.

Stocks to Watch in Animal Health: Zoetis and WOOF Lead the Pack

Animal health stocks are out-performing human health ones. Don't be afraid to take a bite -- there are some great opportunities in this space.

Why Isis Pharmaceuticals, Inc. Exploded Higher By 19% in May

Isis Pharmaceuticals' stock was off to the races again in May. Find out what two factors led shares notably higher last month, and whether this momentum can continue.

The Internet of Things is About to Solve Biotech's Oldest Problem

The field where the Internet of Things is likely to have the biggest impact is often the field no one associates with it: biotech.

3 Best Dividend Stocks in Healthcare

Looking for healthcare stocks with solid dividends that should keep flowing? These three stand out as winners.

5 Freakishly Expensive Cancer Drugs

Prices for cancer medications are soaring.

Upcoming FDA Decisions We're Most Excited About

Three Motley Fool experts tell readers what upcoming FDA decisions have caught their eye.

Forget Gilead Sciences: Here Are 3 Better Biotech Stocks

Biogen Idec, Regeneron, and Amgen Inc. may be better bets than Gilead Sciences.

Regeneron Pharmaceuticals Inc. Earnings: All Eyes on Eylea

Regeneron reported its fourth-quarter and full-year numbers this morning. Here's what investors need to know.

This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market

Opthotech Corporation is researching a new therapy for wet-stage age-related macular degeneration that could have blockbuster potential.

See More BAYRY News...

BAYRY's Top Competitors

BAYRY $0.00 (-100.00%)
Current stock: BAYRY
JNJ $98.44 (-0.03%)
Current stock: JNJ
NVS $99.80 (1.30%)
Current stock: NVS
RHHBY $35.18 (0.10%)
Current stock: RHHBY